Executive Vice President, CFO and Treasurer of Inspire Pharmaceuticals from May 2003 through its $430 million acquisition by Merck & Co., Inc. in May 2011. Prior to joining Inspire, he held senior financial positions of Acting CFO and Treasurer at...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to BioCryst Pharmaceuticals Announces Appointment Of Thomas Staab As Its Next Chief Financial Officer
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account